zalcitabine has been researched along with Hepatitis B Virus Infection in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (85.71) | 18.2507 |
2000's | 2 (9.52) | 29.6817 |
2010's | 1 (4.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M | 1 |
Mitra, AK; Patel, J | 1 |
de Man, RA; Heijtink, RA; Honkoop, P; Schalm, SW | 1 |
Bartholomew, M; Dienstag, JL; Perrillo, RP; Rubin, M; Schiff, ER; Vicary, C | 1 |
Merigan, TC | 1 |
Condreay, LD; Daluge, SM; Ellis, MN; Furman, PA; Jansen, RW; Johnson, LC; Paff, MT; Painter, GR; Powdrill, TF; Selleseth, DW | 1 |
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 2 |
Benhamou, Y; Dohin, E; Gentilini, M; Huraux, JM; Katlama, C; Lunel-Fabiani, F; Opolon, P; Poynard, T | 1 |
Gardner, MF; Hostetler, KY; Korba, BE; Sridhar, CN | 1 |
Cheng, YC; Dutschman, GE; Lin, TS; Liu, MC; Luo, MZ; Pai, SB | 1 |
Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC | 1 |
Grimm, I | 1 |
Korba, BE | 1 |
Bonino, F; d'Urso, N; Ponzetto, A; Zahm, FE | 1 |
Biron, K; Botteron, C; Cecchi, A; Cullen, JM; Davis, MG; Dunn, SE; Frick, L; Goulding, A; Linsey, D; Linzey, D; Paff, MT; Smith, SL | 1 |
Prescott, LM | 1 |
Rubin, M | 1 |
Chang, CN; Cheng, YC; Skalski, V; Zhou, JH | 1 |
Gerber, MA; Lampertico, P; Malter, JS | 1 |
3 review(s) available for zalcitabine and Hepatitis B Virus Infection
Article | Year |
---|---|
ACH-126443 Achillion/Yale University.
Topics: Animals; Clinical Trials as Topic; Hepatitis B; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Technology, Pharmaceutical; Zalcitabine | 2002 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine | 1995 |
2 trial(s) available for zalcitabine and Hepatitis B Virus Infection
Article | Year |
---|---|
A preliminary trial of lamivudine for chronic hepatitis B infection.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine | 1995 |
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Virus Replication; Zalcitabine | 1995 |
16 other study(ies) available for zalcitabine and Hepatitis B Virus Infection
Article | Year |
---|---|
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine | 2012 |
Hepatitis B reactivation after lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Prednisone; Recurrence; Virus Activation; Zalcitabine | 1995 |
A quarter-century of antiviral therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.
Topics: alpha-Fetoproteins; Animals; Antiviral Agents; Biological Availability; Cell Line; DNA, Viral; Emtricitabine; Hepatitis B; Hepatitis B virus; Humans; Mice; Polymerase Chain Reaction; Virus Replication; Zalcitabine | 1994 |
Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice.
Topics: Animals; Antiviral Agents; Drug Carriers; Hepatitis B; Liposomes; Liver; Mice; Phosphatidylglycerols; Prodrugs; Tissue Distribution; Tritium; Zalcitabine | 1994 |
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
Topics: Antiviral Agents; Cells, Cultured; DNA; Hepatitis B; Hepatitis B virus; HIV-1; Stereoisomerism; Virus Replication; Zalcitabine | 1994 |
Viral dynamics in hepatitis B virus infection.
Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine | 1996 |
Lamivudine: a magic bullet for chronic hepatitis B?
Topics: Antiviral Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zalcitabine | 1996 |
In vitro evaluation of combination therapies against hepatitis B virus replication.
Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine | 1996 |
Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP).
Topics: Animals; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA, Viral; Drug Carriers; Female; Hepatitis B; Hepatitis B Virus, Woodchuck; Male; Marmota; Serum Albumin; Viremia; Virus Replication; Zalcitabine | 1996 |
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
Topics: Animals; Antiviral Agents; DNA, Viral; Emtricitabine; Half-Life; Hepatitis B; Hepatitis B Virus, Woodchuck; Liver; Marmota; Stereoisomerism; Zalcitabine | 1997 |
Lamivudine useful against hepatitis B-HIV co-infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Virus Replication; Zalcitabine; Zidovudine | 1995 |
A closer look at 3TC. Interview by Mark Mascolini.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
ViroLogic announces agreement with Achillion.
Topics: Clinical Trials, Phase II as Topic; Cooperative Behavior; Drug Industry; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; Humans; Zalcitabine | 2002 |
Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.
Topics: Antiviral Agents; Base Sequence; Biological Transport; Cells, Cultured; Deoxycytidine Kinase; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Lamivudine; Mitochondria; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides; Phosphorylation; Zalcitabine | 1992 |
Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics.
Topics: Antiviral Agents; Dideoxynucleosides; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Interferon Type I; Stavudine; Vidarabine; Vidarabine Phosphate; Virus Replication; Zalcitabine; Zidovudine | 1991 |